All Biotech Articles

1nhaler has developed a sustainable single use medical inhaler capable of delivering multiple types of dry powder drugs to patients.

Scientists at Northwestern University have developed a new technology that could be a breakthrough in simulating how new drugs will affect the human body.

Founder of iconic apparel company Lululemon (NASDAQ: LULU) is putting $100M into his venture fund to find a cure for facioscapulohumeral muscular dystrophy

Berkley, California based biomaterials startup Bolt Threads has entered into a deal to go public via a SPAC with Golden Arrow Merger Corp (NASDAQ: GAMC)

There’s a new biotech startup focused on cancer research. And the way they got funded might just be the future of scientific ventures.

Radiopharmaceutical treatments for cancer is a highly exciting area of biotech that has been attracting venture capital and public markets investment.

Wall Street hedge fund manager Steve Cohen has taken another big stake in a small publicly traded biotech company called Bionomics.

Peter Thiel has quietly bet on a relatively unknown biotech company called Bionomics that is aiming to treat PTSD.

Toronto based startup Vital Biosciences is building diagnostics technology that aims to radically change blood testing.

Biotech IPOs have been extremely quiet, but these large new public listings show some renewed momentum in the public markets for drug discovery.